BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 19453042)

  • 1. Depth of mesorectal invasion has prognostic significance in T3N0 low rectal cancer.
    Tokoro T; Okuno K; Hida J; Ishimaru E; Ueda K; Yoshifuji T
    Hepatogastroenterology; 2009; 56(89):124-7. PubMed ID: 19453042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
    Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
    Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A clinical study on the degree of mesorectal tumor invasion in middle-low rectal cancer].
    Zhou YB; Zhuo HQ; Li LL; Lv L; Li YJ; Zhou J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Mar; 12(2):159-62. PubMed ID: 19296252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multivariate prognostic analysis of patients with low and middle rectal cancer after curative resection].
    Li CS; Wan DS; Pan ZZ; Zhou ZW; Chen G; Wu XJ; Li LR; Lu ZH; Ding PR; Li Y
    Ai Zheng; 2006 May; 25(5):587-90. PubMed ID: 16687079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
    Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
    J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision.
    Lee SH; Hernandez de Anda E; Finne CO; Madoff RD; Garcia-Aguilar J
    Dis Colon Rectum; 2005 Dec; 48(12):2249-57. PubMed ID: 16400512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multivariate regression analysis of recurrence following curative surgery for colorectal cancer].
    Liang JL; Wan DS; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Wu XJ
    Ai Zheng; 2004 May; 23(5):564-7. PubMed ID: 15142455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesorectal grades predict recurrences after curative resection for rectal cancer.
    Maslekar S; Sharma A; Macdonald A; Gunn J; Monson JR; Hartley JE
    Dis Colon Rectum; 2007 Feb; 50(2):168-75. PubMed ID: 17160574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection.
    Kobayashi H; Mochizuki H; Kato T; Mori T; Kameoka S; Shirouzu K; Sugihara K
    Dis Colon Rectum; 2009 Apr; 52(4):567-76. PubMed ID: 19404054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of anastomosis leakage after curative resection for mid and low rectal cancer.
    Chang SC; Lin JK; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2003; 50(54):1898-902. PubMed ID: 14696429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local recurrence after mesorectal excision for rectal cancer.
    Nesbakken A; Nygaard K; Westerheim O; Mala T; Lunde OC
    Eur J Surg Oncol; 2002 Mar; 28(2):126-34. PubMed ID: 11884047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation of invasion, metastasis, and prognosis in low and middle rectal cancer].
    He WJ; Wang L; Hu H; Kang SY; Qian HX; Xu FM
    Ai Zheng; 2002 Nov; 21(11):1222-5. PubMed ID: 12526220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depth of mesorectal extension has prognostic significance in patients with T3 rectal cancer.
    Shin R; Jeong SY; Yoo HY; Park KJ; Heo SC; Kang GH; Kim WH; Park JG
    Dis Colon Rectum; 2012 Dec; 55(12):1220-8. PubMed ID: 23135579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
    Madbouly KM; Hussein AM; Abdelzaher E
    Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
    Mátrai Z; Lövey J; Hitre E; Orosz Z; Gödény M; Péley G; Sulyok Z; Rényi Vámos F; Farkas E; Köves I
    Orv Hetil; 2006 Oct; 147(42):2011-20. PubMed ID: 17165600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery alone.
    Nissan A; Stojadinovic A; Shia J; Hoos A; Guillem JG; Klimstra D; Cohen AM; Minsky BD; Paty PB; Wong WD
    J Clin Oncol; 2006 Sep; 24(25):4078-84. PubMed ID: 16943525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local excision of distal rectal cancer: an update of cancer and leukemia group B 8984.
    Greenberg JA; Shibata D; Herndon JE; Steele GD; Mayer R; Bleday R
    Dis Colon Rectum; 2008 Aug; 51(8):1185-91; discussion 1191-4. PubMed ID: 18536973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence and survival after mesorectal excision for rectal cancer.
    Bülow S; Christensen IJ; Harling H; Kronborg O; Fenger C; Nielsen HJ; ;
    Br J Surg; 2003 Aug; 90(8):974-80. PubMed ID: 12905551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local recurrence following total mesorectal excision with double-stapling anastomosis for rectal cancers: analysis of risk factors.
    Law WL; Chu KW
    World J Surg; 2002 Oct; 26(10):1272-6. PubMed ID: 12205546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
    Jeyarajah S; Sutton CD; Miller AS; Hemingway D;
    Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.